Tirzepatide

Tirzepatide is a synthetic peptide engineered as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Its unique molecular structure consists of a 39-amino acid sequence with a C20 fatty diacid moiety, which significantly extends its half-life by facilitating binding to albumin. This dual agonism makes Tirzepatide a critical compound for researchers studying complex metabolic pathways and receptor interactions. In experimental models, Tirzepatide is utilized to investigate the synergistic effects of simultaneous GIP and GLP-1 receptor activation. Researchers employ this peptide to study cellular responses related to insulin secretion, glucagon regulation, and lipid metabolism, providing valuable insights into the biochemical foundations of metabolic homeostasis.